Brilliant Violet 421™ anti-mouse IL-2 Antibo-上海雅吉生物科技有限公司

规格	价格	库存
125µL	￥ 2316	1

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

E. coli-expressed, recombinant mouse IL-2

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Preparation

The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.

Concentration

?g size: 0.2 mg/mL
?L size: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

ICFC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the ?l size, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. For flow cytometric staining using the ?g size, the suggested use of this reagent is ≤0.125 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.

Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

Excitation Laser

Violet Laser (405 nm)

Application Notes

ELISA Detection^1-3 or ELISPOT Detection^4-6: The biotinylated JES6-5H4 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with the purified JES6-1A12 antibody (Cat. Nos. 503701 & 503702) as capture antibody and recombinant mouse IL-2 (Cat. No. 575409) as the standard.
Flow Cytometry^8-10: The fluorochrome-labeled JES6-5H4 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IL-2 -producing cells within mixed cell populations.
Neutralization^1,7: The Ultra-LEAF? purified antibody (Endotoxin in vivo and in vitro (Cat. No. 503845-503850)) is recommended for neutralization.
Additional reported applications (for the relevant formats) include: immunoprecipitation¹, immunohistochemical staining of paraformaldehyde-fixed, saponin-treated frozen tissue sections², in vivo capture⁷, and immunocytochemistry.
Note: For testing mouse IL-2 in serum, plasma or supernatant, BioLegend's ELISA MAX? Sets (Cat. No. 431001 & 431004) are specially developed and recommended.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.?

Application References (PubMed link indicates BioLegend citation)

Abrams J, et al. 1992. Immunol. Rev. 127:5.
Sander B, et al. 1993. J. Immunol. Meth. 166:201.
Abrams J. 1995. Curr. Prot. Immunol. John Wiley and Sons New York. Unit 6.20.
Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons New York. Unit 6.19.
Mo X, et al. 1995. J. Virol. 69:1288.
Karulin A, et al. 2000. J. Immunol. 164:1862.
Finkelman F, et al. 2003. Curr. Prot. Immunol. John Wiley & Sons New York. Unit 6.28.
Ko SY, et al. 2005. J. Immunol. 175:3309. PubMed
Kang SS and Allen PM. 2005. J. Immunol. 174:5382.
Lawson BR, et al. 2007. J. Immunol. 178:5366.

Product Citations

Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
Haratani K, et al. 2019. J Clin Invest. 130:374. PubMed
Elong Ngono A, et al. 2020. Cell Reports. 1.330555556. PubMed
Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
Kinder JM, et al. 2020. Cell Reports. 31(12):107784.. PubMed
Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
Bullard BL, et al. 2022. NPJ Vaccines. 7:65. PubMed
Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
Morris AB, et al. 2020. Immunity. 52(1):136-150.e6.. PubMed
Dudeck J, et al. 2019. J Allergy Clin Immunol. 143:1849. PubMed
Marshall N, et al. 2015. Toxicol Sci. 147: 127-139. PubMed
Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
Wen J, et al. 2020. Cell Rep. 31:107566. PubMed

RRID

AB_10895901 (BioLegend Cat. No. 503825) AB_2650897 (BioLegend Cat. No. 503826)

Antigen Details

Structure: Cytokine; 15-30 kD (Mammalian)
Bioactivity: Proliferation of T lymphocytes, B cells, anti-inflammatory, hematopoiesis, tumor surveillance
Cell Sources: T cells
Cell Targets: T cells, B cells, NK cells, LAK cells, monocytes, macrophages, oligodendrocytes
Receptors: High affinity heterotrimer of IL-2Rα/β/γ, intermediate affinity homodimer IL-2Rα (CD25; p55; Tac) and heterodimer IL-2Rβ (CD122)/γ; γ-subunit (CD132) in common with IL-4R, IL-7R, IL-13R, IL-15R
Cell Type: Tregs
Biology Area: Immunology
Molecular Family: Cytokines/Chemokines
Antigen References: 1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. Taniguchi T, et al. 1993. Cell 73:5.
3. Nistico G. 1993. Prog. Neurobiol. 40:463.
4. Waldmann T, et al. 1993. Ann. NY Acad. Sci. 685:603.
Regulation: Upregulated by NFAT; downregulated by TCF-8, CIF (colostrum inhibitory factor)
Gene ID: 16183 View all products for this Gene ID
UniProt: View information about IL-2 on UniProt.org

上海细胞库

原代细胞

细胞培养

细胞服务

酶联试剂盒

生化试剂盒

PCR试剂盒

抗体蛋白

试剂耗材

首页 > 抗体蛋白 > 抗体

产品详情

Product Details

Antigen Details

联系我们